June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Molina Healthcare (MOH) Q4 Earnings, Revenues Beat Estimates

Published 05/04/2017, 09:44 PM
Updated 07/09/2023, 06:31 AM
AAPL
-
AET
-
HUM
-
UNH
-
MOH
-

Molina Healthcare Inc. (NYSE:MOH) reported first-quarter 2017 adjusted net income per share of $1.47 that surpassed the Zacks Consensus Estimate of 57 cents by 157%. Earnings also skyrocketed 188% year over year.

Operational Update

In the first quarter, total revenue of $4.9 billion beat the Zacks Consensus Estimate by 2.6%. The top line has also grown 13% year over year, primarily due to a 16.3% increase in premium revenues and 22% rise in service revenues. A 55% increase in investment income and other revenues also supported the upside.

For the first quarter, total operating expenses rose 13.3% year over year to $4.8 billion due to higher Medical care costs, increased cost of service revenues, a rise in general and administrative expenses, higher premium tax expenses as well as depreciation and amortization costs.

For the first quarter, Medical care cost increased 14.6% year over year to $4.1 billion.

Continuously rising debt burden resulted in Molina Healthcare’s interest expenses increasing 4% year over year to $26 million in the first quarter.

Financial Update

As of Mar 31, 2017, Molina Healthcare’s cash and cash equivalents increased 13.4% from the year-end 2015 level to $3.2 billion.

Total assets grew 8% from the end of 2016 to $85 billion.

Molina Healthcare’s shareholder equity increased 4.7% from year-end 2016 to $1.7 billion.

Net cash from operating activities totaled $719 million in the first quarter, up from $139 million in the year-ago quarter.

2017 Guidance

For 2017, the company expects earnings per diluted share and adjusted earnings per diluted share of $2.53 and $2.90, respectively. It also revised the 2017 outlook to include the impact of the $75 million acquisition termination fee received in the first quarter of 2017.

Molina Healthcare Inc Price, Consensus and EPS Surprise

Zacks Rank and Performance of Other Insurers

Molina Healthcare currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Among the other firms in the medical sector that have reported first-quarter earnings so far, the bottom line at Aetna Inc. (NYSE:AET) , Humana Inc. (NYSE:HUM) and UnitedHealth Group Inc. (NYSE:UNH) beat their respective Zacks Consensus Estimate.

More Stock News: 8 Companies Verge on Apple-Like Run

Did you miss Apple (NASDAQ:AAPL)'s 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.

A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>



Aetna Inc. (AET): Free Stock Analysis Report

Humana Inc. (HUM): Free Stock Analysis Report

Molina Healthcare Inc (MOH): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.